PILOCYTIC ASTROCYTOMA
Clinical trials for PILOCYTIC ASTROCYTOMA explained in plain language.
Never miss a new study
Get alerted when new PILOCYTIC ASTROCYTOMA trials appear
Sign up with your email to follow new studies for PILOCYTIC ASTROCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted cancer drug shows promise but study halted early
Disease control TerminatedThis study tested a drug called tovorafenib in people aged 12 and older whose cancers had returned or worsened and had certain gene changes (MAPK pathway). The goal was to see if the drug could shrink tumors. The study was stopped early, so results are limited.
Matched conditions: PILOCYTIC ASTROCYTOMA
Phase: PHASE2 • Sponsor: Day One Biopharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 03:27 UTC
-
Could a simple fluid test replace brain surgery for kids with tumors?
Knowledge-focused TerminatedThis study looked at whether a liquid biopsy—testing the fluid around the brain and spinal cord—can find tumor DNA in children and young adults with brain tumors. Researchers collected extra samples during routine care from up to 57 participants. The goal was to see if this safer…
Matched conditions: PILOCYTIC ASTROCYTOMA
Sponsor: Pediatric Brain Tumor Consortium • Aim: Knowledge-focused
Last updated May 06, 2026 16:01 UTC